NYSE:NUVB News 19 November 2025

Nuvation Bio (NUVB) Soars After $18 Price-Target Hike – Is This High‑Growth Cancer Stock Still a Buy in 2025?

Nuvation Bio Inc. (NYSE: NUVB) has quietly morphed from an obscure penny stock into one of 2025’s wildest oncology stories. As of December 11, 2025, the stock is trading in the high single digits (around $7.8–$8.0), up roughly 200% year‑to‑date, following a string of clinical wins, a first drug approval, and a wave of fresh analyst upgrades. TipRanks+1 The latest jolt came today, when H.C. Wainwright raised its 12‑month price target on NUVB from $10 to $18 while reiterating a Buy / Strong Buy rating – implying well over 100% upside from recent levels. Investing.com+1 Here’s a deep dive into

11 December 2025

Biotech Stocks·Cancer Research·NYSE:NUVB

Nuvation Bio (NUVB) Stock Soars ~50% Today as B. Riley Starts Coverage With $12 Target – 19 November 2025

NEW YORK, November 19, 2025 – Shares of Nuvation Bio Inc. (NYSE: NUVB) exploded higher on Wednesday after B. Riley Securities initiated coverage with a bullish rating and a $12 price target, adding fresh fuel to a rally driven by the successful launch of the company’s lung cancer drug IBTROZI™ (taletrectinib) and a blockbuster third quarter. Investing.com+2Parameter+2 As of early afternoon on November 19, 2025, NUVB was trading around $7.1–$7.2, up roughly 50% on the day from Tuesday’s close near $4.80, on extremely heavy volume. The stock’s 52‑week range has expanded from about $1.54 at the low to over $7.3

19 November 2025

Biotechnology·Financial Updates·NYSE:NUVB·Stock Market

Bitfarms stock jumps on Keel rebrand and U.S. redomiciliation plan — what BITF investors watch next

7 February 2026

Bitfarms shares jumped 25.2% to $2.14 Friday after the company announced plans to move its legal home to the U.S. and rebrand as Keel Infrastructure, pending a March 20 shareholder vote. The company also said it will repay its $100 million Macquarie debt facility and reported $698 million in net liquidity.

CoreWeave stock jumps 20% as CRWV heads into Feb. 26 earnings — what traders watch next

7 February 2026

CoreWeave shares surged 20.5% to $89.95 Friday, capping a volatile week for AI stocks. The company launched its ARENA lab and a new ad campaign, and set Feb. 26 for its earnings release. SVP Chen Goldberg sold nearly 18,000 shares for tax withholding. A securities class action lawsuit was filed covering trades from March 28 to Dec. 15, 2025.

Arista Networks (ANET) stock jumps into the weekend — here’s what traders watch next week

7 February 2026

Arista Networks shares jumped 6.85% to $137.49 Friday, breaking a two-day slide on volume of about 9 million shares, above average. The move came ahead of Arista’s earnings set for Feb. 12 and U.S. CPI data on Feb. 13. Options pricing signals traders expect volatility around the results. The Dow closed above 50,000 for the first time.

Exxon Mobil stock price just tagged a new high — what could move XOM when markets reopen

7 February 2026

Exxon Mobil shares closed at a 52-week high of $149.05 Friday, up 2.03%, as U.S. energy stocks rallied. Oil prices swung on U.S.-Iran headlines, with Brent settling at $68.05 and WTI at $63.55. Washington imposed new sanctions on Iranian petroleum entities and ships. Exxon plans to release an updated investor presentation on Feb. 20.

NYSE:NUVB News 19 November 2025 - 11 December 2025

Nuvation Bio (NUVB) Soars After $18 Price-Target Hike – Is This High‑Growth Cancer Stock Still a Buy in 2025?

Nuvation Bio (NUVB) Stock Soars ~50% Today as B. Riley Starts Coverage With $12 Target – 19 November 2025

Stock Market Today

Bitfarms stock jumps on Keel rebrand and U.S. redomiciliation plan — what BITF investors watch next

CoreWeave stock jumps 20% as CRWV heads into Feb. 26 earnings — what traders watch next

Arista Networks (ANET) stock jumps into the weekend — here’s what traders watch next week

Exxon Mobil stock price just tagged a new high — what could move XOM when markets reopen